Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Ani Pharmaceuticals (ANIP) over the last 17 years, with Q3 2025 value amounting to -$4.7 million.

  • Ani Pharmaceuticals' Interest & Investment Income fell 10278.85% to -$4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.7 million, marking a year-over-year decrease of 2498.7%. This contributed to the annual value of -$17.6 million for FY2024, which is 3466.22% up from last year.
  • Ani Pharmaceuticals' Interest & Investment Income amounted to -$4.7 million in Q3 2025, which was down 10278.85% from -$5.4 million recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Interest & Investment Income registered a high of -$2.3 million during Q3 2024, and its lowest value of -$7.7 million during Q1 2023.
  • Its 5-year average for Interest & Investment Income is -$5.3 million, with a median of -$5.5 million in 2025.
  • In the last 5 years, Ani Pharmaceuticals' Interest & Investment Income tumbled by 19090.91% in 2022 and then surged by 6356.67% in 2024.
  • Over the past 5 years, Ani Pharmaceuticals' Interest & Investment Income (Quarter) stood at -$4.4 million in 2021, then plummeted by 69.05% to -$7.5 million in 2022, then grew by 23.45% to -$5.7 million in 2023, then fell by 4.68% to -$6.0 million in 2024, then grew by 21.41% to -$4.7 million in 2025.
  • Its Interest & Investment Income was -$4.7 million in Q3 2025, compared to -$5.4 million in Q2 2025 and -$5.5 million in Q1 2025.